RESEARCH ADMINISTRATION

研究管理

• 批准号: 7959134
• 负责人: HENRY LEWIS
• 金额: $ 64.51万
• 依托单位: FLORIDA AGRICULTURAL AND MECHANICAL UNIV
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-06-01 至 2010-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7959134
• 关键词: Advisory Committees; Area; Arts; Award; Computer Retrieval of Information on Scientific Projects Database; Core Facility; Coupled; DNA Microarray Chip; Development; Disease; Ecology; Educational workshop; Evaluation; Evolution; Faculty; Florida; Funding; Gene Expression; Grant; Institutes; Institution; Legal patent; Marketing; Mentors; Molecular; Molecular Neurobiology; Outcome; Pharmacologic Substance; Pharmacy facility; Positioning Attribute; Productivity; Program Evaluation; Proteomics; Research; Research Activity; Research Infrastructure; Research Personnel; Resources; Science; Scientist; Series; Services; Site; Source; Structure; System; Targeted Research; Techniques; United States National Institutes of Health; Universities; abstracting; base; cellular imaging; college; gene delivery system; insight; member; nanomedicine; neurochemistry; professor; programs; receptor; research facility

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. RCMI Local Advisory Committee (RLAC) Administrative Changes: Dr. Henry Lewis III has been reappointed as Dean, College of Pharmacy and Pharmaceutical Sciences, effective July 1, 2007. Dr. R. Turner has been appointed Dean, College of Arts and Sciences, August 2007. Dr. Robert L. Thomas, former Interim Dean of the College of Pharmacy and Dr. Keith Jackson, former Vice President of Research will no longer serve as Ad-Hoc members of the RLAC. Dr. Larry Robinson was appointed as FAMU's Vice President for Research on March 20th. Dr. Robinson served as a professor in the Environmental Sciences Institute at FAMU and director of the National Oceanic and Atmospheric Administration. He will assume his new position later in Spring 2009. Dr. Dale Wesson currently serves as Interim Vice President for Research. Abstract This application seeks to continue the evolution of the Pharmaceutical Research Center at Florida A&M University (FAMU). The previously funded targeted research activities have demonstrated productivity and resulted in significant discoveries that have led to the award of several patents and additional pending discoveries. Based on the evaluation of the current research infrastructure and the strategic needs of the program, it is proposed to transition the targeted activities into the development of Core research facilities. The main objective of the current application is to build the infrastructure of the research program towards more understanding of the mechanistic details of the molecular system. This RCMI center will focus efforts on approaches, i.e., gene expression analysis, proteomics, PCR analysis, gene delivery systems and DNA microarray techniques. The establishment of Core facilities in the areas of molecular neurobiology, cellular imaging, neurochemistry/receptors, flow cytometer and Nanomedicine will increase our abilities to understand the mechanistic details of the molecular system and to provide greater insights into how the different molecular are modulated under disease and adverse conditions. The Pharmaceutical Research Center will consist of a research administrative component coupled with three (3) core service delivery facilities. The administrative component will continue to provide pre- and post- award assistance, coordinate the activities of the external and internal advisory committee, provide scientific seminars and grants workshops, coordinate a new structured mentoring program, facilitate an extensive external evaluation of program outcomes, assist in faculty development, hire a research faculty member and market and conduct an on-site grants management workshop and the annual RCMI R01 Scientist Seminar Series.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 RCMI 地方咨询委员会 (RLAC) 行政变更： Henry Lewis III 博士被重新任命为药学和药物科学学院院长，于 2007 年 7 月 1 日生效。R. Turner 博士于 2007 年 8 月被任命为文理学院院长。药学院前临时院长 Robert L. Thomas 博士和前研究副总裁 Keith Jackson 博士将不再担任 RLAC 的临时成员。 Larry Robinson 博士于 3 月 20 日被任命为 FAMU 负责研究的副校长。罗宾逊博士曾担任 FAMU 环境科学研究所教授和国家海洋和大气管理局局长。他将于 2009 年春季晚些时候就任新职位。Dale Wesson 博士目前担任负责研究的临时副总裁。 抽象的 该应用程序旨在继续佛罗里达农工大学 (FAMU) 药物研究中心的发展。先前资助的有针对性的研究活动已经证明了生产力并产生了重大发现，从而获得了多项专利和其他待决发现。 根据对当前研究基础设施和项目战略需求的评估，建议将目标活动转变为核心研究设施的开发。 当前应用程序的主要目标是建立研究计划的基础设施，以更好地了解分子系统的机制细节。 该 RCMI 中心将重点研究基因表达分析、蛋白质组学、PCR 分析、基因传递系统和 DNA 微阵列技术等方法。分子神经生物学、细胞成像、神经化学/受体、流式细胞仪和纳米医学等领域核心设施的建立将提高我们理解分子系统机制细节的能力，并为不同分子在疾病和不利条件下如何调节提供更深入的见解。 药物研究中心将由一个研究管理部分和三 (3) 个核心服务提供设施组成。行政部门将继续提供授奖前和授奖后协助，协调外部和内部咨询委员会的活动，提供科学研讨会和赠款讲习班，协调新的结构化指导计划，促进对项目成果的广泛外部评估，协助教师发展，聘请研究教员并进行营销和举办现场赠款管理研讨会以及年度 RCMI R01 科学家研讨会系列。